Jed Latkin
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Jed Latkin
Jed Latkin is recorded as CEO and Board Member at Windtree Therapeutics Inc /De/ (WINT). Windtree Therapeutics Inc /De/ reported in an 8-K filed November 14, 2024 that Jed Latkin was appointed President and Chief Executive Officer, effective December 1, 2024. Windtree Therapeutics Inc /De/ reported in an 8-K filed August 14, 2024 that Jed Latkin was appointed Board of Directors, effective August 13, 2024.
“On November 14, 2024, the Company announced the appointment of Jed Latkin, age 50, a current member of the Board, to serve as the Company’s President and Chief Executive Officer, effective as of the Transition Date.”
“On August 13, 2024, the Board appointed Jed Latkin and Saundra Pelletier to fill the vacancies created by the resignation of Mr. Geffken and Ms. Williams, effective August 13, 2024.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2024-08-13–present
-
Current
Start not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Windtree Therapeutics Inc /De/
Other people whose current roles at this company are on record from its filings.
- Craig E. Fraser Chairman, Board Member
- Former Senior VP CFO
- Jamie McAndrew CFO, Chief Accounting Officer
- John Tattory CFO
- Senior VP CFO
- Diane Carman General Counsel
- Andrew Kucharchuk Board Member
- Daniel Geffken Board Member
- Dr. Evan Loh Board Member
- Dr. Robert Scott Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.